WHO Expert Committee on Leprosy.
D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007158:Immunologic Techniques; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D009166:Mycobacterium leprae / Q000187:drug effects / Q000254:growth & development / Q000276:immunology; D014611:Vaccination
D007917:Leprostatic Agents